Newsroom 
- July 19, 2010 –Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos Medical's mild®
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS).
- June 18, 2010 –Vertos Medical Expands Executive Team Amidst Growing Commercial Acceptance of mild®
Medical device company Vertos Medical Inc. has announced the expansion of its senior leadership team with the appointment of Randel W. Woodgrift to senior vice president of operations and research and development, and Ann Deren-Lewis to vice president of marketing. With decades of leadership experience in their respective functional areas, Woodgrift and Deren-Lewis have been tapped to support the accelerating U.S. commercialization of Vertos’ mild* technology for the treatment of lumbar spinal stenosis (LSS).
-
May 24, 2010 – MiDAS I Clinical Study Results Demonstrate Significant Improvement in Patients Treated with mild®
Medical device company Vertos Medical, Inc. has announced the release of additional patient outcomes data from the MiDAS I1 (mild Decompression Alternative to open Surgery) trial, a prospective, 75-patient study of mild* for the treatment of lumbar spinal stenosis (LSS). As presented at the Florida Society of Interventional Pain Physicians (FSIPP) Annual Meeting in Orlando on May 23, investigators found that study participants reported statistically significant improvement in both their physical and mental well-being six weeks following the mild procedure.
- March 12, 2010- Vertos Medical's Prospective Outcomes Study Demonstrates Efficacy, Validates Safety Profile of mild
Medical device company Vertos Medical, Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability.
- February 24, 2010- Acute Study Demonstrates Safety of Vertos Medical's mild Procedure; Findings Appear in Pain Physician Journal
Medical device company Vertos Medical Inc. has reported that an observational study on mild*, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS). The study, conducted by leading pain physicians Timothy Deer, M.D. (The Center for Pain Relief, Charleston, West Va.) and Leonardo Kapural, M.D., Ph.D. (Cleveland Clinic, Cleveland, Ohio), found no reports of patient complications related to the mild devices or technique. - January 21, 2010- Vertos Medical Completes Enrollment in U.S. IRB I Study of mild, Unveils Comprehensive
Clinical Strategy
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure.
-
October 20, 2009- Vertos Medical Closes $15.5 Million Series D Financing
Medical device company Vertos Medical, Inc., developer of the mild(R) procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical
Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
